What We’re Working On

Our scientists take a rigorous and comprehensive approach to understanding cancer biology to drive the discovery of novel medicines and diagnostics. Our aim is to provide cancer therapies and diagnostics to provide a truly individualized approach to treatment.

Hundreds of illnesses affect the brain and its connections to the body. With one of the strongest pipelines in the industry, we are developing medicines for a range of serious neurological diseases.

Viral and bacterial infections are among the leading causes of disease and death. Our research is committed to finding effective treatments for life-threatening infectious diseases.

We're leveraging our expertise in immunology to advance and develop innovative medicines for people living with severe respiratory and autoimmune diseases.

With increasing incidence and the high cost of care of cardiovascular and metabolic diseases, early diagnosis and improved treatment options are important to clinicians, healthcare systems and, above all, to patients.

We assess emerging research technologies such as genomics and informatics tools, and quickly adopt the ones that can enhance our research efforts in finding new drugs and better diagnostic tests.

In ophthalmology, we are researching and developing innovative treatments for people living with a range of eye diseases that cause significant visual impairment and blindness.

Hematology is a branch of medicine that deals with diseases of the blood, such as lymphoma and leukemia. Though diverse in nature, many of these conditions have a serious impact on survival or quality of life.

Hemophilia A is an inherited bleeding disorder where a person’s blood doesn’t clot properly, leading in severe cases to uncontrolled bleeding, either spontaneously or after minor trauma. We are developing novel approaches to hopefully advance the management of this serious disorder.

Our Pharmaceuticals and Diagnostics Divisions enable us to drive personalized healthcare and work across the full spectrum of care, especially in the area of oncology. This is a unique advantage that sets Roche apart from other companies in the industry.

With nearly 30 years in respiratory research, we are focused on improving outcomes for patients with severe respiratory diseases.

Each woman’s health needs are unique and shift throughout her lifetime. We are working in the area of women’s health to improve how women’s diseases are diagnosed with the aim of reducing preventable deaths. Our goal is to equip local healthcare systems with the technology they need to help women manage the range of conditions they face at every stage of their lives.